ID   U17L2_HUMAN             Reviewed;         530 AA.
AC   Q6R6M4;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2008, sequence version 2.
DT   15-MAR-2017, entry version 104.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 17;
DE            Short=USP17;
DE            EC=3.4.19.12 {ECO:0000269|PubMed:14699124, ECO:0000269|PubMed:20228808, ECO:0000269|PubMed:20368735};
DE   AltName: Full=Deubiquitinating enzyme 17-like protein 2;
DE   AltName: Full=Deubiquitinating protein 3;
DE            Short=DUB-3;
DE   AltName: Full=Ubiquitin carboxyl-terminal hydrolase 17-like protein 2;
DE   AltName: Full=Ubiquitin thioesterase 17-like protein 2;
DE   AltName: Full=Ubiquitin-specific-processing protease 17-like protein 2;
GN   Name=USP17L2;
GN   Synonyms=DUB3, USP17, USP17H, USP17I, USP17J, USP17K, USP17L, USP17M;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, INDUCTION BY
RP   CYTOKINES, TISSUE SPECIFICITY, AND MUTAGENESIS OF CYS-89.
RX   PubMed=14699124; DOI=10.1074/jbc.M311291200;
RA   Burrows J.F., McGrattan M.J., Rascle A., Humbert M., Baek K.-H.,
RA   Johnston J.A.;
RT   "DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks
RT   proliferation.";
RL   J. Biol. Chem. 279:13993-14000(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NOMENCLATURE.
RX   PubMed=15780755; DOI=10.1016/j.ygeno.2004.11.013;
RA   Burrows J.F., McGrattan M.J., Johnston J.A.;
RT   "The DUB/USP17 deubiquitinating enzymes, a multigene family within a
RT   tandemly repeated sequence.";
RL   Genomics 85:524-529(2005).
RN   [4]
RP   NOMENCLATURE, AND FUNCTION IN APOPTOSIS.
RX   PubMed=17109758; DOI=10.1186/1471-2164-7-292;
RA   Shin J.-M., Yoo K.-J., Kim M.-S., Kim D., Baek K.-H.;
RT   "Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family
RT   members associated with cell viability.";
RL   BMC Genomics 7:292-292(2006).
RN   [5]
RP   FUNCTION IN CELL PROLIFERATION, AND SUBCELLULAR LOCATION.
RX   PubMed=19188362; DOI=10.1074/jbc.M807216200;
RA   Burrows J.F., Kelvin A.A., McFarlane C., Burden R.E., McGrattan M.J.,
RA   De la Vega M., Govender U., Quinn D.J., Dib K., Gadina M., Scott C.J.,
RA   Johnston J.A.;
RT   "USP17 regulates Ras activation and cell proliferation by blocking
RT   RCE1 activity.";
RL   J. Biol. Chem. 284:9587-9595(2009).
RN   [6]
RP   IDENTIFICATION.
RX   PubMed=20403174; DOI=10.1186/1471-2164-11-250;
RA   Burrows J.F., Scott C.J., Johnston J.A.;
RT   "The DUB/USP17 deubiquitinating enzymes: a gene family within a
RT   tandemly repeated sequence, is also embedded within the copy number
RT   variable beta-defensin cluster.";
RL   BMC Genomics 11:250-250(2010).
RN   [7]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=20388806; DOI=10.1158/0008-5472.CAN-09-4152;
RA   McFarlane C., Kelvin A.A., de la Vega M., Govender U., Scott C.J.,
RA   Burrows J.F., Johnston J.A.;
RT   "The deubiquitinating enzyme USP17 is highly expressed in tumor
RT   biopsies, is cell cycle regulated, and is required for G1-S
RT   progression.";
RL   Cancer Res. 70:3329-3339(2010).
RN   [8]
RP   CATALYTIC ACTIVITY, AND FUNCTION IN CELLULAR ANTIVIRAL RESPONSE.
RX   PubMed=20368735; DOI=10.1038/cr.2010.41;
RA   Chen R., Zhang L., Zhong B., Tan B., Liu Y., Shu H.B.;
RT   "The ubiquitin-specific protease 17 is involved in virus-triggered
RT   type I IFN signaling.";
RL   Cell Res. 20:802-811(2010).
RN   [9]
RP   FUNCTION.
RX   PubMed=20147298; DOI=10.1074/jbc.M109.081448;
RA   de la Vega M., Burrows J.F., McFarlane C., Govender U., Scott C.J.,
RA   Johnston J.A.;
RT   "The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking
RT   and activation but leaves K-Ras unaffected.";
RL   J. Biol. Chem. 285:12028-12036(2010).
RN   [10]
RP   CATALYTIC ACTIVITY, AND FUNCTION IN CELL PROLIFERATION.
RX   PubMed=20228808; DOI=10.1038/ncb2041;
RA   Pereg Y., Liu B.Y., O'Rourke K.M., Sagolla M., Dey A., Komuves L.,
RA   French D.M., Dixit V.M.;
RT   "Ubiquitin hydrolase Dub3 promotes oncogenic transformation by
RT   stabilizing Cdc25A.";
RL   Nat. Cell Biol. 12:400-406(2010).
RN   [11]
RP   FUNCTION, INTERACTION WITH SUDS3, AND SUBCELLULAR LOCATION.
RX   PubMed=21239494; DOI=10.1074/jbc.M110.162321;
RA   Ramakrishna S., Suresh B., Lee E.J., Lee H.J., Ahn W.S., Baek K.H.;
RT   "Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC
RT   activity.";
RL   J. Biol. Chem. 286:10505-10514(2011).
RN   [12]
RP   FUNCTION IN CELL MIGRATION, AND INDUCTION BY CHEMOKINE.
RX   PubMed=21448158; DOI=10.1038/ncomms1243;
RA   de la Vega M., Kelvin A.A., Dunican D.J., McFarlane C., Burrows J.F.,
RA   Jaworski J., Stevenson N.J., Dib K., Rappoport J.Z., Scott C.J.,
RA   Long A., Johnston J.A.;
RT   "The deubiquitinating enzyme USP17 is essential for GTPase subcellular
RT   localization and cell motility.";
RL   Nat. Commun. 2:259-259(2011).
CC   -!- FUNCTION: Deubiquitinating enzyme that removes conjugated
CC       ubiquitin from specific proteins to regulate different cellular
CC       processes. Regulates cell proliferation by deubiquitinating and
CC       inhibiting RCE1 thereby controlling the small GTPases NRAS and
CC       HRAS localization and activation. In parallel, mediates
CC       deubiquitination of CDC25A, preventing CDC25A degradation by the
CC       proteasome during the G1/S and G2/M phases promoting cell-cycle
CC       progression. Also regulates cell proliferation and apoptosis
CC       through deubiquitination of SUDS3 a regulator of histone
CC       deacetylation. Through activation of the Rho family GTPases RAC1A,
CC       CDC42 and RHOA, regulates cell migration. Through the cleavage of
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains of the
CC       cytoplasmic innate immune receptors DDX58 and IFIH1 stimulates the
CC       cellular response to viral infection.
CC       {ECO:0000269|PubMed:14699124, ECO:0000269|PubMed:17109758,
CC       ECO:0000269|PubMed:19188362, ECO:0000269|PubMed:20147298,
CC       ECO:0000269|PubMed:20228808, ECO:0000269|PubMed:20368735,
CC       ECO:0000269|PubMed:20388806, ECO:0000269|PubMed:21239494,
CC       ECO:0000269|PubMed:21448158}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:14699124, ECO:0000269|PubMed:20228808,
CC       ECO:0000269|PubMed:20368735}.
CC   -!- SUBUNIT: Interacts with SUDS3; the interaction is direct.
CC       {ECO:0000269|PubMed:21239494}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21239494}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:19188362}.
CC   -!- TISSUE SPECIFICITY: Broadly expressed.
CC       {ECO:0000269|PubMed:14699124}.
CC   -!- INDUCTION: Up-regulated by IL4/interleukin-4, IL6/interleukin-6
CC       and chemokines including CXCL8 and CXCL12 (at protein level). Up-
CC       regulated during the G1/S transition of the cell cycle.
CC       {ECO:0000269|PubMed:14699124, ECO:0000269|PubMed:20388806,
CC       ECO:0000269|PubMed:21448158}.
CC   -!- MISCELLANEOUS: Overexpressed in a subset of human breast cancers,
CC       overexpression leading to an abnormally high level of CDC25A,
CC       which arrests cells through replication stress or premature
CC       mitosis, the latter occurring when CDK1 is activated
CC       inappropriately. {ECO:0000305|PubMed:20228808}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP17 subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: The RS447 megasatellite DNA is a highly polymorphic
CC       conserved tandem repetitive sequence which contains a copy of the
CC       USP17 gene. It is present with an interindividual variation in
CC       copy number, ranging from 20 to 103, and can be found in the
CC       genome both on chromosome 4 and chromosome 8. USP17 is also
CC       frequently named DUB3 in the literature. The high similarity
CC       between the UPS17-like genes makes impossible to clearly assign
CC       data to one of the genes of the family. Oligonucleotides designed
CC       in RNAi experiments are for instance not specific of a given
CC       UPS17-like gene. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY509884; AAR91701.1; -; mRNA.
DR   EMBL; AC130366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS43713.1; -.
DR   RefSeq; NP_958804.2; NM_201402.2.
DR   UniGene; Hs.531448; -.
DR   ProteinModelPortal; Q6R6M4; -.
DR   SMR; Q6R6M4; -.
DR   BioGrid; 132019; 10.
DR   IntAct; Q6R6M4; 4.
DR   STRING; 9606.ENSP00000333329; -.
DR   MEROPS; C19.023; -.
DR   iPTMnet; Q6R6M4; -.
DR   PhosphoSitePlus; Q6R6M4; -.
DR   BioMuta; USP17L2; -.
DR   DMDM; 187663988; -.
DR   PaxDb; Q6R6M4; -.
DR   PeptideAtlas; Q6R6M4; -.
DR   PRIDE; Q6R6M4; -.
DR   DNASU; 377630; -.
DR   Ensembl; ENST00000333796; ENSP00000333329; ENSG00000223443.
DR   GeneID; 377630; -.
DR   KEGG; hsa:377630; -.
DR   UCSC; uc003wvc.2; human.
DR   CTD; 377630; -.
DR   DisGeNET; 377630; -.
DR   GeneCards; USP17L2; -.
DR   H-InvDB; HIX0034323; -.
DR   HGNC; HGNC:34434; USP17L2.
DR   HPA; HPA045642; -.
DR   MIM; 610186; gene.
DR   neXtProt; NX_Q6R6M4; -.
DR   OpenTargets; ENSG00000223443; -.
DR   PharmGKB; PA165586023; -.
DR   eggNOG; KOG1865; Eukaryota.
DR   eggNOG; ENOG410XQ92; LUCA.
DR   GeneTree; ENSGT00870000136393; -.
DR   HOGENOM; HOG000144638; -.
DR   HOVERGEN; HBG007129; -.
DR   InParanoid; Q6R6M4; -.
DR   KO; K11845; -.
DR   OrthoDB; EOG091G06D5; -.
DR   PhylomeDB; Q6R6M4; -.
DR   TreeFam; TF315281; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   GenomeRNAi; 377630; -.
DR   PRO; PR:Q6R6M4; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0071586; P:CAAX-box protein processing; IMP:UniProtKB.
DR   GO; GO:0000075; P:cell cycle checkpoint; IMP:UniProtKB.
DR   GO; GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB.
DR   GO; GO:0034260; P:negative regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0031064; P:negative regulation of histone deacetylation; IMP:UniProtKB.
DR   GO; GO:0010955; P:negative regulation of protein processing; IMP:UniProtKB.
DR   GO; GO:0090315; P:negative regulation of protein targeting to membrane; IMP:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IMP:UniProtKB.
DR   GO; GO:1900245; P:positive regulation of MDA-5 signaling pathway; IMP:UniProtKB.
DR   GO; GO:1900246; P:positive regulation of RIG-I signaling pathway; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0071108; P:protein K48-linked deubiquitination; IMP:UniProtKB.
DR   GO; GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0050691; P:regulation of defense response to virus by host; IMP:UniProtKB.
DR   GO; GO:1900027; P:regulation of ruffle assembly; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00443; UCH; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Cell cycle; Complete proteome; Endoplasmic reticulum;
KW   Hydrolase; Nucleus; Polymorphism; Protease; Reference proteome;
KW   Thiol protease; Ubl conjugation pathway.
FT   CHAIN         1    530       Ubiquitin carboxyl-terminal hydrolase 17.
FT                                /FTId=PRO_0000331644.
FT   DOMAIN       80    375       USP.
FT   REGION      399    530       Mediates interaction with SUDS3.
FT                                {ECO:0000269|PubMed:21239494}.
FT   ACT_SITE     89     89       Nucleophile.
FT   ACT_SITE    334    334       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   VARIANT     438    438       K -> R (in dbSNP:rs12543578).
FT                                /FTId=VAR_059750.
FT   MUTAGEN      89     89       C->S: Abolishes both enzymatic activity
FT                                and effects on cell proliferation.
FT                                {ECO:0000269|PubMed:14699124}.
FT   CONFLICT     66     66       K -> E (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    214    214       S -> P (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    332    332       D -> N (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    353    353       K -> E (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    357    357       C -> S (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    423    423       R -> H (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    440    440       P -> L (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    462    462       N -> D (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    494    494       R -> P (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    496    496       D -> H (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    500    500       V -> M (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    509    509       Q -> R (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
FT   CONFLICT    512    512       T -> A (in Ref. 1; AAR91701).
FT                                {ECO:0000305}.
SQ   SEQUENCE   530 AA;  59619 MW;  B117BB171376B0E4 CRC64;
     MEDDSLYLGG EWQFNHFSKL TSSRPDAAFA EIQRTSLPEK SPLSSEARVD LCDDLAPVAR
     QLAPRKKLPL SSRRPAAVGA GLQNMGNTCY ENASLQCLTY TPPLANYMLS REHSQTCQRP
     KCCMLCTMQA HITWALHSPG HVIQPSQALA AGFHRGKQED AHEFLMFTVD AMKKACLPGH
     KQVDHHSKDT TLIHQIFGGC WRSQIKCLHC HGISDTFDPY LDIALDIQAA QSVKQALEQL
     VKPEELNGEN AYHCGLCLQR APASKTLTLH TSAKVLILVL KRFSDVTGNK LAKNVQYPEC
     LDMQPYMSQQ NTGPLVYVLY AVLVHAGWSC HDGHYFSYVK AQEGQWYKMD DAKVTACSIT
     SVLSQQAYVL FYIQKSEWER HSESVSRGRE PRALGAEDTD RRATQGELKR DHPCLQAPEL
     DERLVERATQ ESTLDHWKFP QEQNKTKPEF NVRKVEGTLP PNVLVIHQSK YKCGMKNHHP
     EQQSSLLNLS STTRTDQESV NTGTLASLQG RTRRSKGKNK HSKRALLVCQ
//
